During the past decade, Chungbuk national University Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chungbuk national University Hospital" #1 sponsor was "AVEO Pharmaceuticals, Inc." with 1 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chungbuk national University Hospital" #1 collaborator was "Biodesix, Inc." with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Chungbuk national University Hospital" are "Idiopathic Pulmonary Fibrosis" (1 trials), "Metastatic Breast Cancer" (1 trials), "Non-Small Cell Lung Cancer" (1 trials), "Non-small Cell Lung Cancer" (1 trials) and "Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "Chungbuk national University Hospital" in a lesser frequency.

Most popular intervention types in "Chungbuk national University Hospital" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (1 trials), "BSC" (1 trials), "Dinutuximab" (1 trials), "Erlotinib" (1 trials) and "Ficlatuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chungbuk national University Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Chungbuk national University Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Chungbuk national University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Chungbuk national University Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".